Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 20.77 crore in Q3 FY25
Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies, has reported a standalone net profit of Rs. 20.77 crore for the Q3 FY25 ended December 2024 as against a net profit of Rs.
PHINIA Reports Fourth Quarter and Full Year 2024 Results
PHINIA Inc. (NYSE: PHIN), a leader in premium fuel systems, electrical systems, and aftermarket solutions, today reported results for the fourth quarter and full year ended December 31, 2024.
Le Lézard18m
RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMPtm Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery
RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, highlighted its ...
RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, ...